163P Are clinical factors useful for identifying primary progressors (PP) in patients (pts) with hepatocellular carcinoma (HCC) undergoing first-line treatment with atezolizumab plus bevacizumab (AB)? Analysis from the Italian ARTE database
Title:
163P Are clinical factors useful for identifying primary progressors (PP) in patients (pts) with hepatocellular carcinoma (HCC) undergoing first-line treatment with atezolizumab plus bevacizumab (AB)? Analysis from the Italian ARTE database
Author:
Cesario, S. Vivaldi, C. Tovoli, F. Iavarone, M.A. Cabibbo, G. Dalbeni, A. Salani, F. Marra, F. Ponziani, F.R. Soldà , C. Palloni, A. Svegliati-Baroni, G. Pressiani, T. Federico, P. Foschi, F.G. Fornaro, L. Piscaglia, F. Masi, G.